3D Systems ($DDD) Forms Systems Bio to Accelerate Drug Discovery and Development
September 9, 2022 – TheNewswire – 3D systems (JDD) announced the creation of a new wholly owned company named Systemic Bio. The new biotechnology company will focus on the application of advanced bioprinting technologies for pharmaceutical drug discovery and development.
The company says Systemic Bio will leverage its breakthrough production-level bioprinting technology to create highly accurate vascularized organ models using biomaterials and human cells. These proprietary organs-on-a-chip can be reproducibly manufactured in large quantities and then infused with desired drug compounds to study drug metabolism and effects on healthy or diseased tissues in the early stages of new pharmaceutical drug development.
The ability to accurately simulate the human response to an experimental drug in the laboratory, early in the development process, will provide the opportunity to significantly reduce the high costs and extended lead times required for pharmaceutical companies to bring new drugs to market. Additionally, the company says this approach could potentially reduce or even eliminate the need for animal testing as a precursor to large-scale human trials for new drug development.
Dr. Jeffrey Graves, President and CEO of 3D Systems, said, “I am thrilled and inspired by the progress we continue to make in the emerging field of regenerative medicine. The complexity and precision we have now demonstrated using biocompatible materials and our most advanced production bioprinting platform technology is truly revolutionary, opening up a host of new applications from the laboratory to replacement organs in the human body.
3D Systems says it will provide $15 million in seed funding to demonstrate the effectiveness of the technology and associated business model. The company aims for Systemic Bio’s revenue to approach $100 million per year within five years.
3D Systems shares trade on the NYSE under the symbol DDD. For more information, visit www.greenstocknews.com
This content is not financial advice and is for informational, educational and entertainment purposes only. Green Stock News is not responsible for any losses related to financial decisions made by you. Video content and other materials, including web content, are based on data obtained from sources we believe to be reliable, but their accuracy is not guaranteed and are not intended to be complete. As such, the information should not be construed as advice intended to meet the particular investment needs of any investor. Green Stock News is not responsible for any gains or losses resulting from the opinions expressed in this video or materials it publishes electronically.
Watch the original video news clips here: https://greenstocknews.com/green-stock-newswire